It is known that the CV protection effect of GLP-1RAs have been proven through eight large-scale clinical studies, including Evaluation of LIXisenatide in Acute coronary syndrome (ELIXA) [66], LEADER [44], Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN)-6 [67], Exenatide Study of Cardiovascular Event Lowering (EXSCEL) [68], Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes) [69], Researching Cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) [70], Peptide Innovation for Early Diabetes Treatment (PIONEER) 6 [67,71], and AMPLITUDE-O [51]
QuiCalm Discover the benefits of QuiCalm - a premium quality supplement designed to support your health and wellness journey
A.WellerS
These results already have been published in the American Journal of Clinical Nutrition
The 5mg size is perfect for initial studies
Myth: Copper peptides are toxic to the liver Fact: At normal cosmetic or research doses, copper peptides don't stress the liver